Ethylpropyltryptamine (EPT) is a novel orally active psychoactive substance. Ethylpropyltryptamine (EPT) is predicted to be a partial agonist of the 5-HT2A receptor[1].
References
[1] Manier SK, et al. Studies on the In Vitro and In Vivo Metabolic Fate of the New Psychoactive Substance N-Ethyl-N-Propyltryptamine for Analytical Purposes. J Anal Toxicol. 2021 Feb 13;45(2):195-202. DOI:10.1093/jat/bkaa060
